Literature DB >> 3181184

Biodistributions of radioactive alkaline metals in tumor bearing animals: comparison with 201Tl.

A Ando1, I Ando, M Katayama, S Sanada, T Hiraki, H Mori, N Tonami, K Hisada.   

Abstract

The retention values for 42K, 86Rb and 134Cs in the tissues and blood were quite similar to those for 201Tl, but were very different from those for 22Na. In an experiment for subcellular fractionation of tumors, most of these nuclides were localized in the supernatant fraction, with small amounts in other fractions. The concentration ratios for these nuclides in each fraction were approximately constant regardless of the time after administration. Radioactive alkaline metals in the supernatant fraction of the tumor homogenate existed mostly as free ions and were bound to protein in other fractions of tumor tissue. These results were essentially the same as those for 201Tl. Ouabain suppression studies indicated that 201Tl is taken up into the tumor cells partly through Na+, K+-ATPase of their membranes. Ionic radii of alkaline metals and thallium were related to their blood and tumor retention values. This relationship suggested that monovalent cations whose ionic radii exceed 0.133 nm, and which exist as free ions in the tissue fluids, behave like the potassium ion. Potassium and K analogs (Tl, Rb, Cs) are avidly taken up into viable tumor cells whose Na+, K+-ATPase activity is elevated. Therefore, suitable radionuclides of K and K analogs can be excellent agents for visualization of viable tumor tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181184     DOI: 10.1007/bf00254383

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Intercomparison of myocardial imaging agents: 201Ti, 129Cs, 43K, and 81Rb.

Authors:  H Nishiyama; V J Sodd; R J Adolph; E L Saenger; J T Lewis; M Gabel
Journal:  J Nucl Med       Date:  1976-10       Impact factor: 10.057

2.  [Mechanisms of thallium-201 accumulation in the thyroid gland--clinical usefulness of the dynamic study in thallium-201 chloride scintigraphy for the differential diagnosis of thyroid nodules].

Authors:  T Kishida
Journal:  Kaku Igaku       Date:  1987-07

3.  Distribution of 201Tl in the blood.

Authors:  K Nakamura; I Nishiguchi; Y Takagi; A Kubo; S Hashimoto
Journal:  Radioisotopes       Date:  1985-10

4.  Mechanisms of renal lithium handling and their relationship to mineralocorticoids: a dissociation between sodium and lithium ions.

Authors:  L Baer; S R Platman; S Kassir; R R Fieve
Journal:  J Psychiatr Res       Date:  1971-06       Impact factor: 4.791

5.  Study of the distribution of tumor affinity metal compounds and alkaline metal compounds in the tumor tissues by macroautoradiography.

Authors:  A Ando; I Ando; S Sanada; M Katayama; T Hiraki; K Doishita; M Midzukami; K Hisada
Journal:  Int J Nucl Med Biol       Date:  1984

6.  Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments.

Authors:  M Salvatore; L Carratú; E Porta
Journal:  Radiology       Date:  1976-11       Impact factor: 11.105

7.  Mechanism of tumor and liver concentration of 67Ga: 67Ga binding substances in tumor tissues and liver.

Authors:  A Ando; I Ando; T Hiraki; M Takeshita; K Hisada
Journal:  Int J Nucl Med Biol       Date:  1983

8.  Tumor and liver uptake models of 67Ga-citrate.

Authors:  A Ando; I Ando; S Sanada; T Hiraki; K Hisada
Journal:  Eur J Nucl Med       Date:  1985

9.  Biodistributions of 201Tl in tumor bearing animals and inflammatory lesion induced animals.

Authors:  A Ando; I Ando; M Katayama; S Sanada; T Hiraki; H Mori; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1987

10.  Mechanism of tumor and liver concentration of 111In and 169Yb: 111In and 169Yb binding substances in tumor tissues and liver.

Authors:  A Ando; I Ando; T Hiraki; M Takeshita; K Hisada
Journal:  Eur J Nucl Med       Date:  1982
View more
  8 in total

1.  Single photon emission computed tomography using 201Tl chloride in pulmonary nodules: comparison with 67Ga citrate and 99mTc-labeled hexamethylpropyleneamine-oxime.

Authors:  K Itoh; H Takekawa; E Tsukamoto; K Nagao; K Nakada; S Abe; Y Kawakami; M Furudate
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.

Authors:  Y Tokuchi; H Isobe; H Takekawa; T Hanada; T Ishida; S Ogura; K Itoh; M Furudate; K Saito; Y Kawakami
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

3.  Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas.

Authors:  E Tedeschi; A Soricelli; A Brunetti; M Romano; A Bucciero; G Iaconetta; A Alfieri; A Postiglione; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-11

Review 4.  Zirconium. An abnormal trace element in biology.

Authors:  S Ghosh; A Sharma; G Talukder
Journal:  Biol Trace Elem Res       Date:  1992-12       Impact factor: 3.738

5.  Mechanism of 201Tl uptake in tumours.

Authors:  A M Sehweil; J H McKillop; R Milroy; R Wilson; H M Abdel-Dayem; Y T Omar
Journal:  Eur J Nucl Med       Date:  1989

6.  Biodistributions of radioactive bipositive metal ions in tumor-bearing animals.

Authors:  A Ando; I Ando
Journal:  Biometals       Date:  1994-04       Impact factor: 2.949

7.  Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction.

Authors:  Hideaki Shiga; Junichi Taki; Koichi Okuda; Naoto Watanabe; Hisao Tonami; Hideaki Nakagawa; Seigo Kinuya; Takaki Miwa
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

8.  Thallium-201 Imaging in Intact Olfactory Sensory Neurons with Reduced Pre-Synaptic Inhibition In Vivo.

Authors:  Hideaki Shiga; Hiroshi Wakabayashi; Kohshin Washiyama; Tomohiro Noguchi; Tomo Hiromasa; Sadaharu Miyazono; Masami Kumai; Kazuma Ogawa; Junichi Taki; Seigo Kinuya; Takaki Miwa
Journal:  Mol Neurobiol       Date:  2020-08-20       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.